Brief: Inari Medical Announces PEERLESS II, A Randomized Controlled Trial Evaluating Clinical Outcomes Of The Flowtriever System Vs Anticoagulation
22/05/2023 13:13
May 22 (Reuters) - Inari Medical Inc NARI.O :
* INARI MEDICAL ANNOUNCES PEERLESS II, A RANDOMIZED
CONTROLLED
TRIAL EVALUATING CLINICAL OUTCOMES OF THE FLOWTRIEVER® SYSTEM
VERSUS. ANTICOAGULATION IN PULMONARY EMBOLISM PATIENTS
Source text for Eikon: ID:nGNX1sNs4Q
Further company coverage: NARI.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Inari Medical
See all newsJ&J explores bid for Intra-Cellular Therapies, Bloomberg News reports (updated)
U.S. RESEARCH ROUNDUP-GE Healthcare, Summit Materials, Tapestry
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-Annovis Bio, Hoth Therapeutics, Digital Realty
U.S. STOCKS ON THE MOVE-Annovis Bio, Hoth Therapeutics, Digital Realty